France Ovarian Cancer Diagnostics Market Size & Outlook
Related Markets
France ovarian cancer diagnostics market highlights
- The France ovarian cancer diagnostics market generated a revenue of USD 54.4 million in 2024 and is expected to reach USD 102.5 million by 2033.
- The France market is expected to grow at a CAGR of 7.3% from 2025 to 2033.
- In terms of segment, epithelial tumor was the largest revenue generating cancer type in 2024.
- Epithelial Tumor is the most lucrative cancer type segment registering the fastest growth during the forecast period.
Ovarian cancer diagnostics market data book summary
| Market revenue in 2024 | USD 54.4 million |
| Market revenue in 2033 | USD 102.5 million |
| Growth rate | 7.3% (CAGR from 2025 to 2033) |
| Largest segment | Epithelial tumor |
| Fastest growing segment | Epithelial Tumor |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor |
| Key market players worldwide | F. Hoffmann-La Roche Ltd., Johnson & Johnson, GlaxoSmithKline PLC, AstraZeneca PLC, Siemens Healthcare, Abbott, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Quest Diagnostics Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, France accounted for 3.1% of the global ovarian cancer diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany ovarian cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- France is the fastest growing regional market in Europe and is projected to reach USD 102.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ovarian Cancer Diagnostics Market Scope
Ovarian Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GlaxoSmithKline PLC | View profile | - | - | - |
| Siemens Healthcare | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
France ovarian cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ovarian cancer diagnostics market will help companies and investors design strategic landscapes.
Epithelial tumor was the largest segment with a revenue share of 96.88% in 2024. Horizon Databook has segmented the France ovarian cancer diagnostics market based on epithelial tumor, germ cell tumor, stromal cell tumor covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to France ovarian cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France ovarian cancer diagnostics market databook
-
Our clientele includes a mix of ovarian cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France ovarian cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into France ovarian cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
France ovarian cancer diagnostics market size, by cancer type, 2021-2033 (US$M)
France Ovarian Cancer Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
